Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 715

1.

Intracellular FMRpolyG-Hsp70 complex in fibroblast cells from a patient affected by fragile X tremor ataxia syndrome.

Bonapace G, Gullace R, Concolino D, Iannello G, Procopio R, Gagliardi M, Arabia G, Barbagallo G, Lupo A, Manfredini LI, Annesi G, Quattrone A.

Heliyon. 2019 Jun 20;5(6):e01954. doi: 10.1016/j.heliyon.2019.e01954. eCollection 2019 Jun.

PMID:
31294106
Free PMC Article
2.

Functional activity changes in memory and emotional systems of healthy subjects with déjà vu.

Nigro S, Cavalli SM, Cerasa A, Riccelli R, Fortunato F, Bianco MG, Martino I, Chiriaco C, Vaccaro MG, Quattrone A, Gambardella A, Labate A.

Epilepsy Behav. 2019 Jun 7;97:8-14. doi: 10.1016/j.yebeh.2019.05.018. [Epub ahead of print]

PMID:
31181431
3.

A multicenter retrospective study of charcot-marie-tooth disease type 4B (CMT4B) associated with mutations in myotubularin-related proteins (MTMRs).

Pareyson D, Stojkovic T, Reilly MM, Leonard-Louis S, Laurà M, Blake J, Parman Y, Battaloglu E, Tazir M, Bellatache M, Bonello-Palot N, Lévy N, Sacconi S, Guimarães-Costa R, Attarian S, Latour P, Solé G, Megarbane A, Horvath R, Ricci G, Choi BO, Schenone A, Gemelli C, Geroldi A, Sabatelli M, Luigetti M, Santoro L, Manganelli F, Quattrone A, Valentino P, Murakami T, Scherer SS, Dankwa L, Shy ME, Bacon CJ, Herrmann DN, Zambon A, Tramacere I, Pisciotta C, Magri S, Previtali SC, Bolino A.

Ann Neurol. 2019 Jul;86(1):55-67. doi: 10.1002/ana.25500. Epub 2019 May 27.

PMID:
31070812
4.

REM-Sleep Behavior Disorder in Patients With Essential Tremor: What Is Its Clinical Significance?

Salsone M, Arabia G, Manfredini L, Quattrone A, Chiriaco C, Vescio B, Sturniolo M, Morelli M, Nistico' R, Novellino F, Gambardella A, Quattrone A.

Front Neurol. 2019 Apr 24;10:315. doi: 10.3389/fneur.2019.00315. eCollection 2019.

5.

The discovery of beri-beri and scurvy vitamins - two hundred and two years from its discovery.

Piro A, Tagarelli A, Quattrone A.

Int J Vitam Nutr Res. 2019 May 8:1-2. doi: 10.1024/0300-9831/a000435. [Epub ahead of print]

PMID:
31066645
6.

Color vision study to assess the impaired retina-brain cortex pathway in type 2 diabetes: a pilot study in Calabria (Southern Italy).

Piro A, Tagarelli A, Lagonia P, Nicoletti G, Quattrone A.

Neurol Sci. 2019 May 3. doi: 10.1007/s10072-019-03894-4. [Epub ahead of print]

PMID:
31054066
7.

Ultrasensitive detection of cancer biomarkers by nickel-based isolation of polydisperse extracellular vesicles from blood.

Notarangelo M, Zucal C, Modelska A, Pesce I, Scarduelli G, Potrich C, Lunelli L, Pederzolli C, Pavan P, la Marca G, Pasini L, Ulivi P, Beltran H, Demichelis F, Provenzani A, Quattrone A, D'Agostino VG.

EBioMedicine. 2019 May;43:114-126. doi: 10.1016/j.ebiom.2019.04.039. Epub 2019 Apr 29.

8.

Does levodopa have a disease-modifying effect in Parkinson's disease? Evidence from a delayed-start trial.

Barbagallo G, Quattrone A.

Mov Disord. 2019 Jun;34(6):820. doi: 10.1002/mds.27686. Epub 2019 Apr 8. No abstract available.

PMID:
30958571
9.

Are novel outcome measures for Charcot-Marie-Tooth disease sensitive to change? The 6-minute walk test and StepWatch™ Activity Monitor in a 12-month longitudinal study.

Pazzaglia C, Padua L, Pareyson D, Schenone A, Aiello A, Fabrizi GM, Cavallaro T, Santoro L, Manganelli F, Coraci D, Gemignani F, Vitetta F, Quattrone A, Mazzeo A, Russo M, Vita G; CMT-TRIAAL Group.

Neuromuscul Disord. 2019 Apr;29(4):310-316. doi: 10.1016/j.nmd.2019.01.009. Epub 2019 Feb 2.

PMID:
30926199
10.

Hypomorphic mutation of the mouse Huntington's disease gene orthologue.

Murthy V, Tebaldi T, Yoshida T, Erdin S, Calzonetti T, Vijayvargia R, Tripathi T, Kerschbamer E, Seong IS, Quattrone A, Talkowski ME, Gusella JF, Georgopoulos K, MacDonald ME, Biagioli M.

PLoS Genet. 2019 Mar 21;15(3):e1007765. doi: 10.1371/journal.pgen.1007765. eCollection 2019 Mar.

11.

Microstructural changes of normal-appearing white matter in Vascular Parkinsonism.

Salsone M, Caligiuri ME, Vescio V, Arabia G, Cherubini A, Nicoletti G, Morelli M, Quattrone A, Vescio B, Nisticò R, Novellino F, Cascini GL, Sabatini U, Montilla M, Rektor I, Quattrone A.

Parkinsonism Relat Disord. 2019 Mar 1. pii: S1353-8020(19)30092-6. doi: 10.1016/j.parkreldis.2019.02.046. [Epub ahead of print]

PMID:
30852150
12.

Periventricular white matter changes in idiopathic intracranial hypertension.

Sarica A, Curcio M, Rapisarda L, Cerasa A, Quattrone A, Bono F.

Ann Clin Transl Neurol. 2019 Jan 18;6(2):233-242. doi: 10.1002/acn3.685. eCollection 2019 Feb.

13.

Imaging counterpart of postural instability and vertical ocular dysfunction in patients with PSP: A multimodal MRI study.

Quattrone A, Caligiuri ME, Morelli M, Nigro S, Vescio B, Arabia G, Nicoletti G, Nisticò R, Salsone M, Novellino F, Barbagallo G, Vaccaro MG, Sabatini U, Vescio V, Stanà C, Rocca F, Caracciolo M, Quattrone A.

Parkinsonism Relat Disord. 2019 Feb 19. pii: S1353-8020(19)30068-9. doi: 10.1016/j.parkreldis.2019.02.022. [Epub ahead of print]

PMID:
30803901
14.

Refining initial diagnosis of Parkinson's disease after follow-up: A 4-year prospective clinical and magnetic resonance imaging study.

Quattrone A, Morelli M, Vescio B, Nigro S, Le Piane E, Sabatini U, Caracciolo M, Vescio V, Quattrone A, Barbagallo G, Stanà C, Nicoletti G, Arabia G, Nisticò R, Novellino F, Salsone M.

Mov Disord. 2019 Apr;34(4):487-495. doi: 10.1002/mds.27621. Epub 2019 Feb 13.

15.

Methodologies of speech analysis for neurodegenerative diseases evaluation.

Vizza P, Tradigo G, Mirarchi D, Bossio RB, Lombardo N, Arabia G, Quattrone A, Veltri P.

Int J Med Inform. 2019 Feb;122:45-54. doi: 10.1016/j.ijmedinf.2018.11.008. Epub 2018 Nov 26.

PMID:
30623783
16.

Cerebrospinal Fluid Pressure-Related Features in Chronic Headache: A Prospective Study and Potential Diagnostic Implications.

Bono F, Curcio M, Rapisarda L, Vescio B, Bombardieri C, Mangialavori D, Aguglia U, Quattrone A.

Front Neurol. 2018 Dec 18;9:1090. doi: 10.3389/fneur.2018.01090. eCollection 2018.

17.

Screening Approaches for Targeting Ribonucleoprotein Complexes: A New Dimension for Drug Discovery.

D'Agostino VG, Sighel D, Zucal C, Bonomo I, Micaelli M, Lolli G, Provenzani A, Quattrone A, Adami V.

SLAS Discov. 2019 Mar;24(3):314-331. doi: 10.1177/2472555218818065. Epub 2019 Jan 7.

PMID:
30616427
18.

In vivo evidence for decreased scyllo-inositol levels in the supplementary motor area of patients with Progressive Supranuclear Palsy: A proton MR spectroscopy study.

Barbagallo G, Morelli M, Quattrone A, Chiriaco C, Vaccaro MG, Gullà D, Rocca F, Caracciolo M, Novellino F, Sarica A, Arabia G, Sabatini U, Quattrone A.

Parkinsonism Relat Disord. 2019 May;62:185-191. doi: 10.1016/j.parkreldis.2018.12.008. Epub 2018 Dec 11.

PMID:
30558837
19.

Track density imaging in progressive supranuclear palsy: A pilot study.

Nigro S, Bianco MG, Arabia G, Morelli M, Nisticò R, Novellino F, Salsone M, Augimeri A, Quattrone A.

Hum Brain Mapp. 2019 Apr 15;40(6):1729-1737. doi: 10.1002/hbm.24484. Epub 2018 Nov 26.

PMID:
30474903
20.

Editorial: Precision Medicine in Oncology.

Re A, Nardella C, Quattrone A, Lunardi A.

Front Oncol. 2018 Oct 26;8:479. doi: 10.3389/fonc.2018.00479. eCollection 2018. No abstract available.

21.

Gender difference and correlation between sexuality, thyroid hormones, cognitive, and physical functions in elderly fit.

Emerenziani GP, Izzo G, Vaccaro MG, Quattrone A, Lenzi A, Aversa A.

J Endocrinol Invest. 2019 Jun;42(6):699-707. doi: 10.1007/s40618-018-0974-1. Epub 2018 Nov 7.

PMID:
30406377
22.

Active Ribosome Profiling with RiboLace.

Clamer M, Tebaldi T, Lauria F, Bernabò P, Gómez-Biagi RF, Marchioretto M, Kandala DT, Minati L, Perenthaler E, Gubert D, Pasquardini L, Guella G, Groen EJN, Gillingwater TH, Quattrone A, Viero G.

Cell Rep. 2018 Oct 23;25(4):1097-1108.e5. doi: 10.1016/j.celrep.2018.09.084.

23.

The hnRNP raly regulates PRMT1 expression and interacts with the ALS-linked protein FUS: implication for reciprocal cellular localization.

Gasperini L, Rossi A, Cornella N, Peroni D, Zuccotti P, Potrich V, Quattrone A, Macchi P.

Mol Biol Cell. 2018 Oct 24:mbcE18020108. doi: 10.1091/mbc.E18-02-0108. [Epub ahead of print]

24.

Was the subject portrayed in "A Man" by Cornelis Anthonisz around 1530 really affected by progressive supranuclear palsy?

Morelli M, Quattrone A.

Neurol Sci. 2019 Feb;40(2):427-428. doi: 10.1007/s10072-018-3600-2. Epub 2018 Oct 15. No abstract available.

PMID:
30324250
25.

The application of artificial intelligence to understand the pathophysiological basis of psychogenic nonepileptic seizures.

Vasta R, Cerasa A, Sarica A, Bartolini E, Martino I, Mari F, Metitieri T, Quattrone A, Gambardella A, Guerrini R, Labate A.

Epilepsy Behav. 2018 Oct;87:167-172. doi: 10.1016/j.yebeh.2018.09.008. Epub 2018 Sep 28.

26.

Neurobiology of placebo effect in Parkinson's disease: What we have learned and where we are going.

Quattrone A, Barbagallo G, Cerasa A, Stoessl AJ.

Mov Disord. 2018 Aug;33(8):1213-1227. doi: 10.1002/mds.27438. Review.

PMID:
30230624
27.

MRI Asymmetry Index of Hippocampal Subfields Increases Through the Continuum From the Mild Cognitive Impairment to the Alzheimer's Disease.

Sarica A, Vasta R, Novellino F, Vaccaro MG, Cerasa A, Quattrone A; Alzheimer's Disease Neuroimaging Initiative.

Front Neurosci. 2018 Aug 21;12:576. doi: 10.3389/fnins.2018.00576. eCollection 2018.

28.

Preventive effects of bovine colostrum supplementation in TNBS-induced colitis in mice.

Filipescu IE, Leonardi L, Menchetti L, Guelfi G, Traina G, Casagrande-Proietti P, Piro F, Quattrone A, Barbato O, Brecchia G.

PLoS One. 2018 Aug 23;13(8):e0202929. doi: 10.1371/journal.pone.0202929. eCollection 2018.

29.

A new MR imaging index for differentiation of progressive supranuclear palsy-parkinsonism from Parkinson's disease.

Quattrone A, Morelli M, Nigro S, Quattrone A, Vescio B, Arabia G, Nicoletti G, Nisticò R, Salsone M, Novellino F, Barbagallo G, Le Piane E, Pugliese P, Bosco D, Vaccaro MG, Chiriaco C, Sabatini U, Vescio V, Stanà C, Rocca F, Gullà D, Caracciolo M.

Parkinsonism Relat Disord. 2018 Sep;54:3-8. doi: 10.1016/j.parkreldis.2018.07.016. Epub 2018 Jul 25.

PMID:
30068492
30.

Exoskeleton-Robot Assisted Therapy in Stroke Patients: A Lesion Mapping Study.

Cerasa A, Pignolo L, Gramigna V, Serra S, Olivadese G, Rocca F, Perrotta P, Dolce G, Quattrone A, Tonin P.

Front Neuroinform. 2018 Jul 17;12:44. doi: 10.3389/fninf.2018.00044. eCollection 2018.

31.

Analysis of the TMEM230 gene in patients with multiple system atrophy.

Procopio R, Gagliardi M, Brighina L, Nicoletti G, Morelli M, Piatti M, Annesi G, Quattrone A.

J Neurol Sci. 2018 Sep 15;392:128-129. doi: 10.1016/j.jns.2018.07.019. Epub 2018 Jul 23. No abstract available.

PMID:
30056200
32.

Multimodal assessment of normal-appearing corpus callosum is a useful marker of disability in relapsing-remitting multiple sclerosis: an MRI cluster analysis study.

Barone S, Caligiuri ME, Valentino P, Cherubini A, Chiriaco C, Granata A, Filippelli E, Tallarico T, Nisticò R, Quattrone A.

J Neurol. 2018 Oct;265(10):2243-2250. doi: 10.1007/s00415-018-8980-y. Epub 2018 Jul 26.

PMID:
30051273
33.

HuD Is a Neural Translation Enhancer Acting on mTORC1-Responsive Genes and Counteracted by the Y3 Small Non-coding RNA.

Tebaldi T, Zuccotti P, Peroni D, Köhn M, Gasperini L, Potrich V, Bonazza V, Dudnakova T, Rossi A, Sanguinetti G, Conti L, Macchi P, D'Agostino V, Viero G, Tollervey D, Hüttelmaier S, Quattrone A.

Mol Cell. 2018 Jul 19;71(2):256-270.e10. doi: 10.1016/j.molcel.2018.06.032.

34.

Evaluation of machine learning algorithms performance for the prediction of early multiple sclerosis from resting-state FMRI connectivity data.

Saccà V, Sarica A, Novellino F, Barone S, Tallarico T, Filippelli E, Granata A, Chiriaco C, Bruno Bossio R, Valentino P, Quattrone A.

Brain Imaging Behav. 2019 Aug;13(4):1103-1114. doi: 10.1007/s11682-018-9926-9.

PMID:
29992392
35.

DNAJC13 mutation screening in patients with Parkinson's disease from South Italy.

Gagliardi M, Annesi G, Procopio R, Morelli M, Iannello G, Bonapace G, Mancini M, Nicoletti G, Quattrone A.

Parkinsonism Relat Disord. 2018 Oct;55:134-137. doi: 10.1016/j.parkreldis.2018.06.004. Epub 2018 Jun 4.

PMID:
29887357
36.

Clinical, electrophysiological, and imaging study in essential tremor-Parkinson's disease syndrome.

Arabia G, Lupo A, Manfredini LI, Vescio B, Nisticò R, Barbagallo G, Salsone M, Morelli M, Novellino F, Nicoletti G, Quattrone A, Cascini GL, Louis ED, Quattrone A.

Parkinsonism Relat Disord. 2018 Nov;56:20-26. doi: 10.1016/j.parkreldis.2018.06.005. Epub 2018 Jun 5.

PMID:
29885986
37.

SRSF2 mutations drive oncogenesis by activating a global program of aberrant alternative splicing in hematopoietic cells.

Liang Y, Tebaldi T, Rejeski K, Joshi P, Stefani G, Taylor A, Song Y, Vasic R, Maziarz J, Balasubramanian K, Ardasheva A, Ding A, Quattrone A, Halene S.

Leukemia. 2018 Dec;32(12):2659-2671. doi: 10.1038/s41375-018-0152-7. Epub 2018 Jun 1.

38.

Mutational analysis of TARDBP gene in patients affected by Parkinson's disease from Calabria.

Gagliardi M, Arabia G, Nisticò R, Iannello G, Procopio R, Manfredini L, Annesi G, Quattrone A.

J Neurol Sci. 2018 Jul 15;390:209-211. doi: 10.1016/j.jns.2018.04.043. Epub 2018 May 1.

PMID:
29801890
39.

Autophagy inhibition improves the cytotoxic effects of receptor tyrosine kinase inhibitors.

Aveic S, Pantile M, Polo P, Sidarovich V, De Mariano M, Quattrone A, Longo L, Tonini GP.

Cancer Cell Int. 2018 Apr 24;18:63. doi: 10.1186/s12935-018-0557-4. eCollection 2018.

40.

Midbrain meningioma causing subacute parkinsonism.

Labate A, Nisticò R, Cherubini A, Quattrone A.

Neurol Clin Pract. 2018 Apr;8(2):166-168. doi: 10.1212/CPJ.0000000000000439. No abstract available.

41.

A High-Content Screening of Anticancer Compounds Suggests the Multiple Tyrosine Kinase Inhibitor Ponatinib for Repurposing in Neuroblastoma Therapy.

Sidarovich V, De Mariano M, Aveic S, Pancher M, Adami V, Gatto P, Pizzini S, Pasini L, Croce M, Parodi F, Cimmino F, Avitabile M, Emionite L, Cilli M, Ferrini S, Pagano A, Capasso M, Quattrone A, Tonini GP, Longo L.

Mol Cancer Ther. 2018 Jul;17(7):1405-1415. doi: 10.1158/1535-7163.MCT-17-0841. Epub 2018 Apr 25.

42.

Positioning Europe for the EPITRANSCRIPTOMICS challenge.

Jantsch MF, Quattrone A, O'Connell M, Helm M, Frye M, Macias-Gonzales M, Ohman M, Ameres S, Willems L, Fuks F, Oulas A, Vanacova S, Nielsen H, Bousquet-Antonelli C, Motorin Y, Roignant JY, Balatsos N, Dinnyes A, Baranov P, Kelly V, Lamm A, Rechavi G, Pelizzola M, Liepins J, Holodnuka Kholodnyuk I, Zammit V, Ayers D, Drablos F, Dahl JA, Bujnicki J, Jeronimo C, Almeida R, Neagu M, Costache M, Bankovic J, Banovic B, Kyselovic J, Valor LM, Selbert S, Pir P, Demircan T, Cowling V, Schäfer M, Rossmanith W, Lafontaine D, David A, Carre C, Lyko F, Schaffrath R, Schwartz S, Verdel A, Klungland A, Purta E, Timotijevic G, Cardona F, Davalos A, Ballana E, O Carroll D, Ule J, Fray R.

RNA Biol. 2018;15(6):829-831. doi: 10.1080/15476286.2018.1460996. Epub 2018 May 9.

43.

Hydrogen peroxide is a neuronal alarmin that triggers specific RNAs, local translation of Annexin A2, and cytoskeletal remodeling in Schwann cells.

Negro S, Stazi M, Marchioretto M, Tebaldi T, Rodella U, Duregotti E, Gerke V, Quattrone A, Montecucco C, Rigoni M, Viero G.

RNA. 2018 Jul;24(7):915-925. doi: 10.1261/rna.064816.117. Epub 2018 Apr 11.

44.

Antidepressant-like actions by silencing of neuronal ELAV-like RNA-binding proteins HuB and HuC in a model of depression in male mice.

Sanna MD, Quattrone A, Galeotti N.

Neuropharmacology. 2018 Jun;135:444-454. doi: 10.1016/j.neuropharm.2018.04.001. Epub 2018 Apr 5.

PMID:
29626565
45.

Editorial on special issue: Machine learning on MCI.

Sarica A, Cerasa A, Quattrone A, Calhoun V.

J Neurosci Methods. 2018 May 15;302:1-2. doi: 10.1016/j.jneumeth.2018.03.011. Epub 2018 Mar 23. No abstract available.

PMID:
29581008
46.

The placebo effect on resting tremor in Parkinson's disease: an electrophysiological study.

Barbagallo G, Nisticò R, Vescio B, Cerasa A, Olivadese G, Nigro S, Crasà M, Quattrone A, Bianco MG, Morelli M, Augimeri A, Salsone M, Novellino F, Nicoletti G, Arabia G, Quattrone A.

Parkinsonism Relat Disord. 2018 Jul;52:17-23. doi: 10.1016/j.parkreldis.2018.03.012. Epub 2018 Mar 14.

PMID:
29551396
47.

Cancer cell metabolic plasticity allows resistance to NAMPT inhibition but invariably induces dependence on LDHA.

Thongon N, Zucal C, D'Agostino VG, Tebaldi T, Ravera S, Zamporlini F, Piacente F, Moschoi R, Raffaelli N, Quattrone A, Nencioni A, Peyron JF, Provenzani A.

Cancer Metab. 2018 Mar 8;6:1. doi: 10.1186/s40170-018-0174-7. eCollection 2018.

48.
49.

Cardiac parasympathetic index identifies subjects with adult obstructive sleep apnea: A simultaneous polysomnographic-heart rate variability study.

Salsone M, Vescio B, Quattrone A, Roccia F, Sturniolo M, Bono F, Aguglia U, Gambardella A, Quattrone A.

PLoS One. 2018 Mar 8;13(3):e0193879. doi: 10.1371/journal.pone.0193879. eCollection 2018.

50.

Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients.

Manna I, Iaccino E, Dattilo V, Barone S, Vecchio E, Mimmi S, Filippelli E, Demonte G, Polidoro S, Granata A, Scannapieco S, Quinto I, Valentino P, Quattrone A.

FASEB J. 2018 Aug;32(8):4241-4246. doi: 10.1096/fj.201701533R. Epub 2018 Mar 5.

PMID:
29505299

Supplemental Content

Loading ...
Support Center